 | Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma |
| | Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In |
| | Apotex receives Health Canada approval for Aflivuâ„¢, a biosimilar to Eylea®, available in pre-filled syringe and vial formats |
| | Sandoz, on a $1.1B investment spree in Slovenia, breaks ground at new $440M biosimilar plant |
| | Latest from FDA: Zoryve foam, more psoriasis biosimilars, Keytruda for skin cancer |
| | Sandoz Further Asserts Leadership In Biosimilars, Breaking Ground On New Slovenia Facility To Expand European Biosimilar Hub And Global Market Reach |
| | Health Canada approves Biocon's Yesafili, biosimilar to Eylea |
| | Sunshine Biopharma’s Canadian subsidiary, Nora Pharma launches biosimilar drug, Niopeg |